QA: Seelos Therapeutics INC in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001017491_2021_Seelos_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001017491, Seelos Therapeutics INC

  xvar xval
0 AssetsCurrent 17,494,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 7,429,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 7,493,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 7,862,517
9 ResearchAndDevelopmentExpense 14,134,685
10 remainder_Expenses 0
11 remainder_Revenues 131,676
12 remainder_NetIncome -6,527,527
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 17,494,000
1 Liabilities 14,922,000
2 Expenses 21,997,202
3 Revenues 131,676
4 StockholdersEquity 2,572,000
5 NetIncome -28,393,053
6 ComprehensiveNetIncome -28,393,053
7 BaseVar 30,536,202
8 EconomicCapitalRatiobeforeLimitedLiability -1.41
9 EconomicCapitalRatio 1.20

Edgar->Model Mapping

Feature Distribution

Change over Time